Grants for Independent school districts - Food and Nutrition

This grant provides financial support to schools and early learning services in Washington state for purchasing and preparing nutritious, locally sourced foods to improve children's meal programs and promote healthy eating habits.

This funding opportunity is designed to support clinical centers conducting research on the development of Type 1 diabetes following episodes of acute pancreatitis, focusing on understanding its causes, progression, and risk factors in a diverse population.

This grant provides funding for innovative, interdisciplinary research projects that aim to advance understanding and treatment of diseases related to diabetes, digestive disorders, liver diseases, metabolic and nutritional disorders, kidney and urologic diseases, and obesity.

This funding opportunity provides financial support to state and local governments, educational institutions, nonprofits, and other organizations to implement strategies that promote better nutrition and physical activity, ultimately reducing chronic disease risks in their communities.

This funding opportunity supports U.S. institutions in developing educational programs that provide undergraduate and early-stage graduate students with hands-on research experiences in kidney technology development and entrepreneurship.

This funding opportunity is designed to support researchers investigating the connections between HIV/AIDS and various health issues related to diabetes, digestive, kidney, and metabolic diseases, particularly focusing on the complications and social factors affecting people living with HIV.

Not available

The Building Healthy Communities: Middle School Program, sponsored by Blue Cross Blue Shield of Michigan, is a grant opportunity designed to provide physical, mental, and emotional health support to Michigan schools, students, and staff. This program emphasizes a whole-child approach to health, recognizing the diverse needs of school communities across the state. It offers flexible instructional options, including in-person and virtual learning, and allows schools to prioritize investments in critical areas such as mental health, self-care, and physical activity resources. The program's mission aligns with fostering sustainable cultures of wellness in schools through education, policy, and environmental change. The primary beneficiaries of this program are middle school students in 5th, 6th, or 7th grade attending eligible public, charter, or private nonprofit schools in Michigan. The program also indirectly benefits school staff and the broader school community by promoting a healthier environment. The overarching impact goal is to establish knowledge and behaviors for a healthy lifestyle that lasts a lifetime, starting from a young age. This is achieved by tailoring health and wellness initiatives to the unique needs of each school. The program's key priorities and focuses are to encourage students to: eat more fruits and vegetables, choose fewer sugary food and beverages, eat less fast and fatty food, be active every day, and spend less entertainment time in front of screens. These specific goals guide the implementation of health and wellness initiatives within participating schools. Expected outcomes include a significant improvement in students' dietary habits and physical activity levels. While not explicitly detailed in the provided text, the measurable results would likely track changes in student consumption of healthy foods, reduction in sugary and fatty foods, increased daily physical activity, and decreased screen time for entertainment, all contributing to a healthier student population. The foundation's strategic priorities, as evidenced by this grant, include promoting community health, especially among youth, and addressing the identified needs for physical, mental, and emotional health support within the Michigan school system. The theory of change appears to be that by partnering with schools and implementing tailored health and wellness initiatives, students will develop healthier habits and contribute to a sustainable culture of wellness within their school communities, ultimately leading to improved long-term health outcomes.

This grant provides funding to organizations that promote vaccine confidence and health equity through partnerships and educational outreach, particularly targeting underserved populations across the United States.

The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes management and quality of life. Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. Projects will be funded to a) develop and test new technologies and b) to adapt and test existing technologies. It is expected that aging-adaptive diabetes technologies that address barriers for use among older adults with T1D will improve usability, adoption and adherence decreasing the risk of hypoglycemia (and hypoglycemia unawareness) while enhancing glycemic control, facilitating better diabetes management, and improving quality of life for these individuals and their caregivers.

This funding opportunity supports independent research projects in health-related fields for a wide range of eligible applicants, including universities, nonprofits, and small businesses, without allowing clinical trials.

This funding opportunity provides substantial financial support to higher education institutions and nonprofit organizations to establish collaborative centers that advance research and resources for HIV/AIDS.

This grant provides funding to nonprofit organizations, government entities, school districts, and faith-based groups in Springfield, Missouri, to support programs that empower youth and encourage their participation in community service.

This funding opportunity provides financial support to schools and school districts to conduct a pilot study aimed at reducing harmful contaminants in meals served to students and improving their nutritional quality.

The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization may be submitted to this FOA. This assumes such a change is programmatically permitted for the particular grant. Applications for change of recipient organization are considered prior approval requests (as described in Section 8.1.2.7 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award. Although requests for change of recipient organization may be submitted through this FOA, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.

Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged period of time. Accidental exposure of these products to alcohol can result in the relatively rapid release of large quantities of drug with severe side effects, including death. To mitigate this risk, the FDA recommends conducting an in vitro alcohol dose dumping assessment in 0%, 5%, 20%, and 40% alcoholic dissolution media for all prospective generic versions of MR oral drug products. To date, ADD assessments have not been harmonized globally. For instance, the U.S. FDA recommends testing up to 40% alcoholic media while the European Medicines Agency recommends testing up to 20% alcoholic media. This type of difference can present a challenge for formulators designing products for multiple markets, as historical data has shown release from MR oral products do not always follow a linear response (either increasing or decreasing) to increasing alcohol concentrations. In addition, interpretation of an ADD assessment may be limited by the inability of the test to predict in vivo behavior. The purpose of this research is to develop tools that 1) facilitate the development of MR generic drug products that have a low potential for ADD, 2) support regulatory decision making during the assessment of such products, and 3) provide evidence that enables FDA to develop more specific recommendations for efficiently demonstrating a low or comparative potential of alcohol dose dumping for MR oral drug products containing high risk drugs.

This funding opportunity supports researchers in discovering and validating new targets for developing safe and effective pain treatments with minimal side effects and low addiction risk.

This funding opportunity provides financial support for organizations involved in child nutrition programs in Idaho to upgrade their technology systems and improve operational efficiency.

This Funding Opportunity Announcement (FOA) seeks innovative grant applications in nonmalignant hematology research that will steer the field in new directions. Applications to this FOA should propose proof of principle research that is tightly focused into one specific aim, which can be accomplished within a 1-3 year project period, and is directed at validating novel concepts and approaches that promise to open new pathways for discovery.The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Aging (NIA) have joined together to build research activities in nonmalignant hematology. This Funding Opportunity Announcement (FOA) is intended to promote innovative research projects in nonmalignant hematology that explore high impact and new directions of inquiry. While each Institute shares interests in nonmalignant hematology research, they also bring different perspectives, thereby expanding the scope of the SHINE II program beyond a single Institute's research mission. This "New Directions in Hematology Research (SHINE-II)" program invites investigator-initiated grant applications for basic or early translational, proof of principle research projects that are tightly focused and directed at validating novel concepts and approaches that promise to advance new pathways for discovery. This program may include clinical research involving human subjects that is directed at understanding disease pathogenesis and prognosis. Research applications submitted under this FOA should be more limited in scope (single aim with sub-aims, as appropriate) and duration (1-3 years) than typical R01 grant applications. The SHINE-II FOA seeks specifically to promote and support new directions of research in their early stages. Applications submitted to this FOA should include preliminary data that support the conceptual basis of the research proposed and the technical approaches to be used. Moreover, while research applications submitted under this FOA are expected to be more limited in scope and shorter in duration than typical R01 applications, achievement of the research objective(s) proposed should validate novel pathways of discovery and provide the basis for future high impact research endeavors. Principal areas of interest for this collaborative FOA include: (1) hematopoietic stem cell biology, (2) lineage fate determinants, (3) aging-related immune dysfunction and lymphocyte biology, (4) myeloid cell biology, and myelopoiesis, (5) platelet biology and dysfunction, (6) erythroid cell biology and erythropoiesis, (7) the molecular biology of heme and hemoglobin, (8) acquired and congenital disorders of red blood cell production and survival leading to chronic anemia or bone marrow failure, (9) and the uptake, utilization, storage, and transport of iron in health and disease. Inquiries to Scientific/Research staff prior to submission of an application to this FOA are strongly encouraged to discuss programmatic relevance and potential time tables for funding (see below, Section VII. Agency Contacts). The limited scope and shorter duration of the SHINE II R01 are not optimal for Early Stage Investigators (ESIs) and New Investigators (NIs), who should contact Scientific/Research staff prior to submission of an application to this FOA.

The City of Boulder Health Equity Fund (HEF) Request for Proposals (RFP) is designed to support community-based health equity programs for Boulder residents experiencing health disparities. The fund aims to reduce systemic socio-economic and health barriers, aligning with the city's mission to achieve health equity—defined as the absence of systematic health disparities and the ability of all residents to reach their full health potential regardless of life circumstances. This initiative directly supports health and wellness programs that address these disparities. The target beneficiaries of the HEF include residents disproportionately impacted by diseases linked to sugar-sweetened beverage consumption or targeted by SSB marketing, those lacking access to healthy food, safe water, quality health care, wellness information, and health care services, and populations systemically disenfranchised due to race, ethnicity, income, age, ability, sexual orientation, or gender identification. The primary impact goal is to improve health equity and reduce health disparities within these vulnerable communities. The HEF prioritizes programs that benefit individuals most affected by or at increased risk from chronic diseases linked to sugary drink consumption, or who generally experience health disparities. Key focuses include health services for prevention of obesity, diabetes, heart disease, and oral diseases, increased access to healthy food and clean water, wellness programs, and physical fitness. The program also emphasizes leadership diversity reflective of client demographics, alignment with program priorities, evidence-based practices, and valuing lived experience and cultural knowledge. Expected outcomes and measurable results include long-term evaluation of outcomes, meaningful engagement of community members in program design and implementation, strong collaborations, cost-effectiveness, and demonstrated financial stability and diverse funding sources for applying agencies. The City of Boulder's strategic priority is to fund programs that directly address health inequities and contribute to a community where all residents can achieve their full health potential. The underlying theory of change is that by investing in targeted, community-based health and wellness programs, the city can systematically dismantle health barriers and create a more equitable health landscape for its residents.